Pear claims breakthrough tag for alcohol use disorder DTx
pharmaphorum
NOVEMBER 24, 2021
reSET-O was the first prescription DTx ever to win a breakthrough device designation from the FDA, according to Pear , allowing it to tap into a programme intended to speed up the development and regulatory review of new therapies so they can reach patients sooner. Photo by thom masat on Unsplash.
Let's personalize your content